156 related articles for article (PubMed ID: 19857794)
41. [Drug regulation in Spain].
Rubio Terrés C
Med Clin (Barc); 1992 May; 98(19):741-8. PubMed ID: 1608280
[No Abstract] [Full Text] [Related]
42. Distinguishing between expert and statistical systems for application under ICH M7.
Barber C; Hanser T; Judson P; Williams R
Regul Toxicol Pharmacol; 2017 Mar; 84():124-130. PubMed ID: 28057482
[No Abstract] [Full Text] [Related]
43. Assessment of the genotoxic and carcinogenic risks of p-nitrophenol when it is present as an impurity in a drug product.
Eichenbaum G; Johnson M; Kirkland D; O'Neill P; Stellar S; Bielawne J; DeWire R; Areia D; Bryant S; Weiner S; Desai-Krieger D; Guzzie-Peck P; Evans DC; Tonelli A
Regul Toxicol Pharmacol; 2009 Oct; 55(1):33-42. PubMed ID: 19500632
[TBL] [Abstract][Full Text] [Related]
44. Toxicological analysis points to a lower tolerable daily intake of melamine in food.
Hsieh DP; Chiang CF; Chiang PH; Wen CP
Regul Toxicol Pharmacol; 2009 Oct; 55(1):13-6. PubMed ID: 19486917
[TBL] [Abstract][Full Text] [Related]
45. Ethyl methanesulphonate in a parenteral formulation of BMS-214662 mesylate, a selective farnesyltransferase inhibitor: formation and rate of hydrolysis.
Nassar MN; Cucolo M; Miller SA
Pharm Dev Technol; 2009; 14(6):672-7. PubMed ID: 19883257
[TBL] [Abstract][Full Text] [Related]
46. Dose response considerations in risk assessment--an overview of recent ILSI activities.
Holsapple MP; Wallace KB
Toxicol Lett; 2008 Aug; 180(2):85-92. PubMed ID: 18588961
[TBL] [Abstract][Full Text] [Related]
47. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
48. Heat stable formulation of Norvir appears likely.
Dalton P
Proj Inf Perspect; 2008 Sep; (46):10. PubMed ID: 19043878
[No Abstract] [Full Text] [Related]
49. Toxicological overview of impurities in pharmaceutical products.
Jacobson-Kram D; McGovern T
Adv Drug Deliv Rev; 2007 Jan; 59(1):38-42. PubMed ID: 17188779
[TBL] [Abstract][Full Text] [Related]
50. Refining the threshold of toxicological concern (TTC) for risk prioritization of trace chemicals in food.
Felter S; Lane RW; Latulippe ME; Llewellyn GC; Olin SS; Scimeca JA; Trautman TD
Food Chem Toxicol; 2009 Sep; 47(9):2236-45. PubMed ID: 19531369
[TBL] [Abstract][Full Text] [Related]
51. Is the acceptable daily intake as presently used an axiom or a dogma?
Galli CL; Marinovich M; Lotti M
Toxicol Lett; 2008 Aug; 180(2):93-9. PubMed ID: 18588960
[TBL] [Abstract][Full Text] [Related]
52. The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment.
Calabrese EJ
Arch Toxicol; 2009 Mar; 83(3):203-25. PubMed ID: 19247635
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugs.
Flentge CA; Randolph JT; Huang PP; Klein LL; Marsh KC; Harlan JE; Kempf DJ
Bioorg Med Chem Lett; 2009 Sep; 19(18):5444-8. PubMed ID: 19679477
[TBL] [Abstract][Full Text] [Related]
54. Establishing a point of departure for risk assessment using acute inhalation toxicology data.
Rusch GM; Bast CB; Cavender FL
Regul Toxicol Pharmacol; 2009 Aug; 54(3):247-55. PubMed ID: 19427887
[TBL] [Abstract][Full Text] [Related]
55. [Drug registries: post-marketing evaluation of the benefit-risk profile and promotion of appropriateness. The regional point of view].
Martelli L; Venegoni M
Recenti Prog Med; 2013 Jun; 104(6):272-4. PubMed ID: 23801232
[TBL] [Abstract][Full Text] [Related]
56. Regulatory aspects of chemical mutagenesis in Italy and in the European Community.
Carere A
Ann Ist Super Sanita; 1989; 25(4):605-9. PubMed ID: 2631627
[TBL] [Abstract][Full Text] [Related]
57. Resistance mechanism revealed by crystal structures of unliganded nelfinavir-resistant HIV-1 protease non-active site mutants N88D and N88S.
Bihani SC; Das A; Prashar V; Ferrer JL; Hosur MV
Biochem Biophys Res Commun; 2009 Nov; 389(2):295-300. PubMed ID: 19720046
[TBL] [Abstract][Full Text] [Related]
58. Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes.
Blossom D; Noble-Wang J; Su J; Pur S; Chemaly R; Shams A; Jensen B; Pascoe N; Gullion J; Casey E; Hayden M; Arduino M; Budnitz DS; Raad I; Trenholme G; Srinivasan A;
Arch Intern Med; 2009 Oct; 169(18):1705-11. PubMed ID: 19822828
[TBL] [Abstract][Full Text] [Related]
59. [Dutch drug registration: greater openness is urgently desired].
Toenders WG; van Loenhout JW
Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2051-4. PubMed ID: 9550762
[TBL] [Abstract][Full Text] [Related]
60. A perspective on testing of existing pharmaceutical excipients for genotoxic impurities.
Brusick DJ
Regul Toxicol Pharmacol; 2009 Nov; 55(2):200-4. PubMed ID: 19607870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
